Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

Clinical trial NCT03872401 · COMPLETED

Trial details

NCT number: NCT03872401
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Heart Disease (CHD)

Start date: 2019-06-11
Primary completion: 2025-07-25
Enrollment: 12301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.